These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 17581322)
1. Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients. Pawlak K; Pawlak D; Mysliwiec M Blood Coagul Fibrinolysis; 2007 Jul; 18(5):467-71. PubMed ID: 17581322 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin therapy decreased tissue factor, its pathway inhibitor, and oxidative stress in peritoneal dialysis patients with diabetes. Pawlak K; Pawlak D; Mysliwiec M Nephron Clin Pract; 2007; 107(1):c20-5. PubMed ID: 17671395 [TBL] [Abstract][Full Text] [Related]
3. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress effects fibrinolytic system in dialysis uraemic patients. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Atli T; Keven K; Avci A; Kutlay S; Turkcapar N; Varli M; Aras S; Ertug E; Canbolat O Arch Gerontol Geriatr; 2004; 39(3):269-75. PubMed ID: 15381345 [TBL] [Abstract][Full Text] [Related]
6. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. Pawlak K; Pawlak D; Myśliwiec M Med Sci Monit; 2006 Apr; 12(4):CR181-5. PubMed ID: 16572054 [TBL] [Abstract][Full Text] [Related]
7. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. Pawlak K; Zolbach K; Borawski J; Mysliwiec M; Kovalchuk O; Chyczewski L; Pawlak D Thromb Res; 2008; 123(1):166-70. PubMed ID: 18452978 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567 [TBL] [Abstract][Full Text] [Related]
9. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease. Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487 [TBL] [Abstract][Full Text] [Related]
10. The evaluation of the oxidative stress parameters in nondiabetic and diabetic senile cataract patients. Yildirim Z; Yildirim F; Ucgun NI; Kilic N Biol Trace Elem Res; 2009 May; 128(2):135-43. PubMed ID: 18982249 [TBL] [Abstract][Full Text] [Related]
11. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients. Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433 [TBL] [Abstract][Full Text] [Related]
12. Levels of superoxide dismutase and malondialdehyde in primary spontaneous pneumothorax. Tabakoglu E; Ciftci S; Hatipoglu ON; Altiay G; Caglar T Mediators Inflamm; 2004 Jun; 13(3):209-10. PubMed ID: 15223614 [TBL] [Abstract][Full Text] [Related]
13. Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism. Cetinkaya A; Kurutas EB; Buyukbese MA; Kantarceken B; Bulbuloglu E Mediators Inflamm; 2005 Feb; 2005(1):57-9. PubMed ID: 15770068 [TBL] [Abstract][Full Text] [Related]
14. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733 [TBL] [Abstract][Full Text] [Related]
15. [Hemostasis in patients with diabetes mellitus. II. Tissue factor and the extrinsic blood coagulation inhibitor]. Galajda P; Martinka E; Kubisz P; Ivanková J; Ochodnický M; Polko J; Mokán M Vnitr Lek; 1996 Nov; 42(11):776-8. PubMed ID: 9012122 [TBL] [Abstract][Full Text] [Related]
16. [Markers of oxidative balance and concentration of selected metals in pollinotics]. Długosz A; Liebhart J; Piotrowska D; Dor A; Liebhart E Przegl Lek; 2005; 62(12):1328-31. PubMed ID: 16786741 [TBL] [Abstract][Full Text] [Related]
17. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker. Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955 [TBL] [Abstract][Full Text] [Related]
18. Nutritional status and oxidative processes in diabetic and nondiabetic peritoneal dialysis patients. Malgorzewicz S; Lichodziejewska-Niemierko M; Rutkowski B; Lysiak-Szydlowska W J Ren Nutr; 2004 Oct; 14(4):242-7. PubMed ID: 15483785 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in children with acute glomerulonephritis. Bülbül M; Oner A; Demircin G; Erdoğan O Ren Fail; 2008; 30(2):209-14. PubMed ID: 18300123 [TBL] [Abstract][Full Text] [Related]
20. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Pan HZ; Zhang H; Chang D; Li H; Sui H Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]